These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach. Wu K; Goyal N; Stark JG; Hochhaus G J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243 [TBL] [Abstract][Full Text] [Related]
27. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze. Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460 [TBL] [Abstract][Full Text] [Related]
28. Adrenal insufficiency from inhaled corticosteroids. White A; Woodmansee DP Ann Intern Med; 2004 Mar; 140(6):W27. PubMed ID: 15023738 [No Abstract] [Full Text] [Related]
29. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. Volovitz B; Bilavsky E; Nussinovitch M J Asthma; 2008 Sep; 45(7):561-7. PubMed ID: 18773327 [TBL] [Abstract][Full Text] [Related]
30. Inhaled corticosteroids, adrenal suppression and benign intracranial hypertension. Patradoon-Ho P; Gunasekera H; Ryan MM; Ambler GR Med J Aust; 2006 Sep; 185(5):279-80. PubMed ID: 16948626 [No Abstract] [Full Text] [Related]
31. Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult. Hindmarsh P BMJ; 2002 May; 324(7345):1083. PubMed ID: 11993494 [No Abstract] [Full Text] [Related]
32. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129 [TBL] [Abstract][Full Text] [Related]
34. Aseptic femoral head necrosis in a patient receiving long term courses of inhaled and intranasal corticosteroids. Karkoulias K; Charokopos N; Kaparianos A; Sampsonas F; Tsiamita M; Spiropoulos K Tuberk Toraks; 2007; 55(2):182-5. PubMed ID: 17602347 [TBL] [Abstract][Full Text] [Related]
35. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
37. A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma. Iles R; Williams RM; Deeb A; Ross-Russell R; Acerini CL Pediatr Pulmonol; 2008 Apr; 43(4):354-9. PubMed ID: 18286548 [TBL] [Abstract][Full Text] [Related]
38. Adrenal insufficiency after treatment with fluticasone. Second line controller treatment might have been tried. Lipworth BJ BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12376451 [No Abstract] [Full Text] [Related]